Firm
Regulatory changes and damages risks are prompting Canadian firms and clients to opt for settlements in generic and biosimilar cases
A new claim filed by Ericsson, and a request for access to documents, were also among recent developments
Matthew Grady of Wolf Greenfield says AI presents an opportunity in patent practice for stronger collaboration between in-house and outside counsel
Discussion hosted by Bird & Bird partners also hears that UK courts’ desire to determine FRAND rates could see the jurisdiction penalised in a similar way to China
Sponsored
Sponsored
-
Sponsored by RNA, Technology and IP AttorneysThe Working Statement which patentees need to file every year continues to be a controversial subject. The frequent changes in the forms and varying stands of the patent office have added to the confusion.
-
Sponsored by Januar Jahja & PartnersIn the midst of a pandemic that has disrupted economic activity so much so that Indonesia recently entered its first recession in over two decades, a proposed law on job creation brought thousands of protesters out to Jakarta's now almost deserted streets. The law weakens worker and environmental protections in the name of increasing business ease and underwent a somewhat unconventional and confusing path to implementation (there were four separate final drafts circulating at one point with differences of hundreds of pages). As a result, the law has been controversial from beginning to end. In its final form, it is over 1,100 pages long and amends approximately 75 separate laws, packaged together as the Job Creation Law No. 11 of Year 2020 or just the Omnibus Bill.
-
Sponsored by AJ ParkA recent trademark decision by the Intellectual Property Office of New Zealand (IPONZ) reveals the importance of submitting reliable and probative evidence in invalidation proceedings, even when the invalidation proceedings are undefended by the trademark owner.
-
Sponsored by Bird & BirdCharlotte Kilpatrick joins Steve Mortinger of IBM and Toby Bond and Katharine Stephens of Bird & Bird to discuss how data rights are reshaping IP
-
Sponsored by Liu, Shen & AssociatesArtificial intelligence (AI) is a technology that simulates human intelligence. It performs tasks that usually require human intelligence, such as visual perception, natural speech recognition and language translation.
-
Sponsored by Shiga International Patent OfficeAmid the coronavirus pandemic, pioneering pharmaceutical makers, research institutes, and universities are working in collaboration to develop novel antiviral drugs that are small compounds and vaccines. Although most inventions produced this year will be disclosed when their patent applications are published next year, the inventions being developed before this pandemic have already been disclosed.